Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

174 results

In hoeverre leent de WAMCA-procedure zich voor massaschadeclaims op grond van de AVG?

Binnen de massaschadepraktijk speelt al langer de vraag in hoeverre het mogelijk is om middels een WAMCA-procedure schadevergoeding te vorderen voor een vermeende inbreuk op de AVG.

The European Health Data Space (EHDS): new opportunities and obligations for healthcare institutions

The European Health Data Space (EHDS) will enter into force on 25 March 2025. The aim of the new European Regulation (EU) 2025/327 on the EHDS is to optimise the exchange of and access to health information within the EU.

Freya Trouw

Associate Amsterdam

Collectieve actie tegen geneesmiddelenfabrikant over excessieve prijzen

St. Farma ter Verantwoording startte een collectieve actie tegen fabrikant AbbVie wegens het hanteren van een excessieve prijs voor het medicijn Humira. De rechtbank Amsterdam oordeelt echter dat de stichting onvoldoende belang heeft bij de vorderingen.

Tom Barkhuysen

Partner Amsterdam

Tom Barkhuysen

Partner Amsterdam

Stibbe advises Aedifica

Stibbe has advised Aedifica on the further expansion of its healthcare real estate portfolio in the Netherlands with the acquisition and lease of 2 elderly care residences in Oss and Dordrecht.

Repsol: Dutch parent company cannot simply be used as anchor defendant to create jurisdiction

Foreign entities are often sued in the Netherlands on the basis of the ‘anchor defendant’ construction.

Repsol: Nederlandse moedervennootschap kan niet zomaar als ankergedaagde worden gebruikt om rechtsmacht te creëren

Buitenlandse partijen worden vaak in Nederland gedagvaard via de "ankergedaagde"-constructie.

Ali al Khatib

Senior Associate Amsterdam

Tim de Greve

Partner Amsterdam

Branda Katan

Partner Amsterdam

Pagination

  • Previous page
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
Reset filters
Date
Content type
  • Article (53)
  • Event (4)
  • Inside Stibbe (2)
  • Interview (1)
  • Matter (59)
  • Podcast (3)
  • People (52)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • (-) Mass Litigation (92)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (438)
  • Capital Markets (251)
  • Compliance, Sanctions and Risk (161)
  • Corporate and M&A (888)
  • Corporate Investigations (32)
  • Criminal Law and Enforcement (151)
  • Employment, Benefits and Pensions (426)
  • Energy, Industry and Climate (322)
  • Environment and Planning (922)
  • ESG & Sustainability (312)
  • EU and Competition Law (489)
  • Financial Regulation (179)
  • Infrastructure and Mobility (206)
  • Insurance (36)
  • Intellectual Property (121)
  • Investment Funds (147)
  • Litigation and Arbitration (441)
  • Privacy and Data Protection (206)
  • Private Equity (199)
  • Procurement Law (127)
  • Public Law (1227)
  • Real Estate (491)
  • Restructuring and Insolvency (116)
  • Sports (27)
  • Tax (459)
  • Tech (197)
  • Technology, Media and Telecommunications (340)
  • Unfair Competition and Consumer Protection (200)
Jurisdiction
  • BE Law (24)
  • EU Law (25)
  • LU Law (7)
  • NL Law (94)
Language
  • Dutch (24)
  • English (148)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information